🇺🇸 Anti-platelet therapy in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Pain — 1 report (10%)
2. Asthenia — 1 report (10%)
3. Cerebrovascular Disorder — 1 report (10%)
4. Chronic Kidney Disease — 1 report (10%)
5. Chronic Obstructive Pulmonary Disease — 1 report (10%)
6. Colitis Ischaemic — 1 report (10%)
7. Convulsion — 1 report (10%)
8. Defaecation Urgency — 1 report (10%)
9. Dehydration — 1 report (10%)
10. Drug Hypersensitivity — 1 report (10%)

Source database →

Frequently asked questions

Is Anti-platelet therapy approved in United States?

Anti-platelet therapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Anti-platelet therapy in United States?

Boston Scientific Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.